Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
9.19M
-
Shares change
-
-278K
-
Total reported value, excl. options
-
$144M
-
Value change
-
-$4.19M
-
Number of buys
-
27
-
Number of sells
-
-10
-
Price
-
$15.89
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2019
53 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q4 2019.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.19M shares
of 92.4M outstanding shares and own 9.95% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.41M shares), ORBIMED ADVISORS LLC (1.48M shares), BlackRock Inc. (727K shares), FMR LLC (636K shares), VANGUARD GROUP INC (572K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (445K shares), Fosun International Ltd (413K shares), STATE STREET CORP (225K shares), GEODE CAPITAL MANAGEMENT, LLC (163K shares), and NORTHERN TRUST CORP (141K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.